118 related articles for article (PubMed ID: 16548991)
1. Comparative study of the ThinPrep Pap test and conventional cytology results in a Canadian cohort.
Duggan MA; Khalil M; Brasher PM; Nation JG
Cytopathology; 2006 Apr; 17(2):73-81. PubMed ID: 16548991
[TBL] [Abstract][Full Text] [Related]
2. ThinPrep detection of cervical and endometrial adenocarcinoma: a retrospective cohort study.
Schorge JO; Hossein Saboorian M; Hynan L; Ashfaq R
Cancer; 2002 Dec; 96(6):338-43. PubMed ID: 12478681
[TBL] [Abstract][Full Text] [Related]
3. Liquid-based cervical cytology.
Klinkhamer PJ; Meerding WJ; Rosier PF; Hanselaar AG
Cancer; 2003 Oct; 99(5):263-71. PubMed ID: 14579292
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the ThinPrep Pap test in clinical practice. A seven-month, 16,314-case experience in northern Vermont.
Papillo JL; Zarka MA; St John TL
Acta Cytol; 1998; 42(1):203-8. PubMed ID: 9479341
[TBL] [Abstract][Full Text] [Related]
5. [Applicative aspects of liquid-based cytology in cervical cancer screening].
Liverani M; De Paola F; Danesi S; Fedriga R; Dalbuoni V; Agnoletti R; Amadori AR; Mirra F; Bonoli W; Saragoni L
Pathologica; 2006 Dec; 98(6):629-34. PubMed ID: 17285839
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of p16INK4a as a diagnostic tool in the triage of Pap smears demonstrating atypical squamous cells of undetermined significance.
Duncan L; Jacob S; Hubbard E
Cancer; 2008 Feb; 114(1):34-48. PubMed ID: 18186493
[TBL] [Abstract][Full Text] [Related]
7. Cytohistologic correlation rates between conventional Papanicolaou smears and ThinPrep cervical cytology: a comparison.
Chacho MS; Mattie ME; Schwartz PE
Cancer; 2003 Jun; 99(3):135-40. PubMed ID: 12811853
[TBL] [Abstract][Full Text] [Related]
8. Rare atypical squamous cells of undetermined significance (ASCUS): a clinically significant diagnosis?
Hoerl HD; Roth-Cline MD; Shalkham JE; Pfister J; Stewart J; Guo Z; De Las Casas LE; Caya JG; Kurtycz DF
Diagn Cytopathol; 2002 Jul; 27(1):5-9. PubMed ID: 12112807
[TBL] [Abstract][Full Text] [Related]
9. ThinPrep Papanicolaou testing to reduce false-negative cervical cytology.
Linder J; Zahniser D
Arch Pathol Lab Med; 1998 Feb; 122(2):139-44. PubMed ID: 9499356
[TBL] [Abstract][Full Text] [Related]
10. ThinPrep Pap Test promotes detection of glandular lesions of the endocervix.
Bai H; Sung CJ; Steinhoff MM
Diagn Cytopathol; 2000 Jul; 23(1):19-22. PubMed ID: 10907926
[TBL] [Abstract][Full Text] [Related]
11. Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS).
Walker JL; Wang SS; Schiffman M; Solomon D;
Am J Obstet Gynecol; 2006 Aug; 195(2):341-8. PubMed ID: 16890545
[TBL] [Abstract][Full Text] [Related]
12. Performance and cost analysis of Siriraj liquid-based cytology: a direct-to-vial study.
Laiwejpithaya S; Benjapibal M; Laiwejpithaya S; Wongtiraporn W; Sangkarat S; Rattanachaiyanont M
Eur J Obstet Gynecol Reprod Biol; 2009 Dec; 147(2):201-5. PubMed ID: 19747757
[TBL] [Abstract][Full Text] [Related]
13. Liquid-based cytology for primary cervical cancer screening: a multi-centre study.
Monsonego J; Autillo-Touati A; Bergeron C; Dachez R; Liaras J; Saurel J; Zerat L; Chatelain P; Mottot C
Br J Cancer; 2001 Feb; 84(3):360-6. PubMed ID: 11161401
[TBL] [Abstract][Full Text] [Related]
14. Liquid-based cytology and conventional smears compared over two 12-month periods.
Williams AR
Cytopathology; 2006 Apr; 17(2):82-5. PubMed ID: 16548992
[TBL] [Abstract][Full Text] [Related]
15. Squamous cervical lesions in women with human immunodeficiency virus: long-term follow-up.
Massad LS; Seaberg EC; Wright RL; Darragh T; Lee YC; Colie C; Burk R; Strickler HD; Watts DH
Obstet Gynecol; 2008 Jun; 111(6):1388-93. PubMed ID: 18515523
[TBL] [Abstract][Full Text] [Related]
16. Chlamydia trachomatis and Pap testing from a single, fluid-based sample. A multicenter study.
Inhorn SL; Wand PJ; Wright TC; Hatch KD; Hallum J; Lentrichia BB
J Reprod Med; 2001 Mar; 46(3):237-42. PubMed ID: 11304865
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of the ThinPrep monolayer technique and conventional cervical Pap smears in a high-risk population using the Munich II nomenclature].
Lellé RJ; Cordes A; Regidor M; Maier E; Flenker H
Gynakol Geburtshilfliche Rundsch; 2007; 47(2):81-7. PubMed ID: 17440269
[TBL] [Abstract][Full Text] [Related]
18. Resolution of equivocal results with the Hybrid Capture II high-risk HPV DNA test: a cytologic/histologic review of 191 cases.
Knoepp SM; Kuebler DL; Wilbur DC
Diagn Mol Pathol; 2007 Sep; 16(3):125-9. PubMed ID: 17721319
[TBL] [Abstract][Full Text] [Related]
19. Impact of the more restrictive definition of atypical squamous cells introduced by the 2001 Bethesda System on the sensitivity and specificity of the Papanicolaou test: a 5-year follow-up study of Papanicolaou tests originally interpreted as ASCUS, reclassified according to Bethesda 2001 criteria.
Thrall MJ; Pambuccian SE; Stelow EB; McKeon DM; Miller L; Savik K; Gulbahce HE
Cancer; 2008 Jun; 114(3):171-9. PubMed ID: 18454461
[TBL] [Abstract][Full Text] [Related]
20. Direct-to-vial comparison of a new liquid-based cytology system, liqui-PREP versus the conventional pap smear.
Park J; Jung EH; Kim C; Choi YH
Diagn Cytopathol; 2007 Aug; 35(8):488-92. PubMed ID: 17636495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
